NCT02170584View on ClinicalTrials.gov

Tolerability of BIBR 953 ZW IV and Bioavailability of BIBR 1048 Tablet and Solution in Healthy Males

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

March 31, 2001

Conditions
Healthy
Interventions
DRUG

BIBR 953 ZW IV

DRUG

BIBR 1048 MS tablet

DRUG

BIBR 1048 MS oral solution

DRUG

BIBR 953 ZW IV Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02170584 - Tolerability of BIBR 953 ZW IV and Bioavailability of BIBR 1048 Tablet and Solution in Healthy Males | Biotech Hunter | Biotech Hunter